Client News

Spexis announces presentation of half-year 2022 financial results and participation at upcoming industry and investor events in September

Carbios’ Chief Scientific Officer Alain Marty Receives the Prestigious Biocat Award

Marinomed Biotech AG continues its growth path and reports strong financials in H1 2022

Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility

ABIVAX ANNOUNCES A CHANGE IN ITS GOVERNANCE

Rentschler Biopharma Expands Leadership Team with Senior-Level Hires

Carbios: WhiteCycle: A European consortium to recycle plastic waste

nova funds: Gesundheitsaktienfonds nova Steady HealthCare offiziell als nachhaltiges Investment klassifiziert

InflaRx Reports Second Quarter 2022 Financial & Operating Results

ABIVAX PHASE 3 PROGRAM WITH OBEFAZIMOD IN ULCERATIVE COLITIS PROGRESSES WITH US IRB APPROVAL